Home › Clot risk in Lilly lung-cancer drug raises FDA concerns
 

Keywords :   


Clot risk in Lilly lung-cancer drug raises FDA concerns

2015-07-07 21:33:35| Biotech - Topix.net

Eli Lilly and Co.' s experimental lung cancer drug has raised concerns with U.S. regulators that it may increase patients' risk of suffering potentially deadly blood clots.

Tags: risk drug concerns raises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11MSX2
24.11CITY 1-13
24.11 Loveyoursself Soul DVD
24.11B787-8 1/400
24.11GIANT CONTEND SL1105
24.11HappySanrio characters Halloween
24.11
24.11emmi
More »